Phase I study of oncolytic virus (OV) MG1 maraba/MAGE-A3 (MG1MA3), with and without transgenic MAGE-A3 adenovirus vaccine (AdMA3) in incurable advanced/metastatic MAGE-A3-expressing solid tumours: ...
Improving the maturity of its ICT operations over the past two years has helped DPV Health – a not-for-profit provider of health care services to expand its services. It also set the foundation for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results